MedTrace Logo

Brief Intervention for Medication Overuse Headache

NCT01314768 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 123

Last updated 2015-12-30

No results posted yet for this study

Summary

The investigators will perform a cluster randomised controlled study of Brief intervention (BI) for medication-overuse headache (MOH) versus business as usual. GPs will be trained to perform a structured brief intervention after identifying patients with probable MOH using the severity of dependence scale. The control arm will include patients of GPs who have not been trained in BI. Patients will be recruited by prior short postal screening of patients listed on the GPs patient lists.

The hypothesis is that BI will lead to improvement of medication-overuse and chronic headache as compared to no BI.

Main outcomes are:

* number of medication days per month
* number of headache days per month
* headache index

Conditions

  • Medication-overuse Headache
  • Chronic Headache

Interventions

BEHAVIORAL

Brief intervention

Structured behavioural Brief intervention given by trained GPs

OTHER

Business as usual

GPs to treat patient as they have until now based on best established practice

OTHER

Screening and outcome evaluation only

No additional intervention

OTHER

Screening and outcome evaluation only

No additional intervention

Sponsors & Collaborators

  • University of Oslo

    collaborator OTHER

  • University Hospital, Akershus

    lead OTHER

Principal Investigators

  • Christofer Lundqvist, MD, PhD · Akershus University Hospital and University of Oslo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2012-11-30
Completion
2013-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01314768 on ClinicalTrials.gov